Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | CASP3 | P42574 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.43 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.43 |
| ▸ | G6PD | P11413 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | PMM2 | O15305 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | MPI | P34949 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29436003 | 1.00 | GPR3 (0.43) | GPR3ALDH1A1CASP3MAPTKDM4E | |
| SCHEMBL13781133 | 0.83 | ALDH1A1 (0.39) | GPR3ALDH1A1CASP3MAPTKDM4E | |
| SCHEMBL6067705 | 0.72 | CDK4 (0.44) | ALDH1A1CASP3MAPTKDM4EDDAH1 | |
| SCHEMBL31458576 | 0.69 | — | — | |
| SCHEMBL3107062 | 0.69 | — | — | |
| SCHEMBL3075163 | 0.68 | GPR3 (0.43) | GPR3ALDH1A1CASP3MAPTKDM4E | |
| SCHEMBL11148877 | 0.67 | GPR3 (0.42) | GPR3ALDH1A1CASP3MAPTKDM4E | |
| Lithium SCHEMBL11145683 | 0.67 | GPR3 (0.42) | GPR3ALDH1A1CASP3MAPTKDM4E | |
| SCHEMBL9160474 | 0.65 | GPR3 (0.68) | GPR3ALDH1A1CASP3MAPTKDM4E | |
| SCHEMBL30515127 | 0.65 | GPR3 (0.68) | GPR3ALDH1A1CASP3MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 892 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4526944-A1 | THTOCARBONATE COMPOSITIONS FOR LITHIUM- SULFUR BATTERIES | Conamix Inc. (US) | 2025-03-26 | — | — | EP | claimed |
| EP-3475292-B1 | SYNTHESIS OF THIOLATED OLIGONUCLEOTIDES WITHOUT A CAPPING STEP | BIOGEN MA INC (US) | 2024-09-18 | — | — | EP | claimed |
| WO-2023225261-A1 | THTOCARBONATE COMPOSITIONS FOR LITHIUM- SULFUR BATTERIES | CONAMIX INC. (US) | 2023-11-23 | — | — | WO | claimed |
| CN-108473526-B | Process for producing oligonucleotide and nucleoside, nucleotide or oligonucleotide | 味之素株式会社 | 2022-08-09 | — | — | CN | claimed |
| EP-3950698-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE HAVING PHOSPHOROTHIOATE SITE | AJINOMOTO CO., INC. (JP) | 2022-02-09 | — | — | EP | claimed |
| US-20220010348-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE HAVING PHOSPHOROTHIOATED SITE | AJINOMOTO CO., INC. (JP) | 2022-01-13 | — | — | US | claimed |
| CN-113631564-A | Method for producing oligonucleotide having phosphorothioate moiety | 味之素株式会社 | 2021-11-09 | — | — | CN | claimed |
| US-10919928-B2 | Oligonucleotide production method, and nucleoside, nucleotide, or oligonucleotide | AJINOMOTO CO., INC. (JP) | 2021-02-16 | — | — | US | claimed |
| WO-2020196890-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE HAVING PHOSPHOROTHIOATE SITE | 味の素株式会社 | 2020-10-01 | — | — | WO | claimed |
| EP-3398955-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD, AND NUCLEOSIDE, NUCLEOTIDE, OR OLIGONUCLEOTIDE | AJINOMOTO CO., INC. (JP) | 2018-11-07 | — | — | EP | claimed |
| US-5616700-A | GENETIC ENGINEERING | BECKMAN INSTRUMENTS, INC. (US) | 1997-04-01 | — | — | US | claimed |
| WO-1996039413-A1 | METHODS AND COMPOUNDS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES AND THE OLIGONUCLEOTIDES THEREBY PRODUCED | HYBRIDON, INC. (US) | 1996-12-12 | — | — | WO | claimed |
| EP-0746614-A1 | METHOD AND REAGENT FOR INHIBITING THE EXPRESSION OF DISEASE RELATED GENES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1996-12-11 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| WO-1996014277-A1 | SYNTHESIS OF 35S-LABELED OLIGONUCLEOTIDES WITH 3H-1,2-BENZODITHIOL-3-1,1-DIOXIDE | HYBRIDON, INC. (US) | 1996-05-17 | — | — | WO | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| WO-1995023225-A2 | METHOD AND REAGENT FOR INHIBITING THE EXPRESSION OF DISEASE RELATED GENES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1995-08-31 | — | — | WO | claimed |
| WO-1995014029-A1 | PROTECTED OLIGONUCLEOSIDES AND THEIR USE IN HIGH YIELDING SYNTHESIS OF DNA AND ANTISENSE DNA | BECKMAN INSTRUMENTS, INC. (US) | 1995-05-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220010348-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE HAVING PHOSPHOROTHIOATED SITE | RNGTT, NUDT1, ADAR | GPR3 3997/4885ALDH1A1 3105/4885CASP3 1240/4885 |
| US-10919928-B2 | Oligonucleotide production method, and nucleoside, nucleotide, or oligonucleotide | POLL, POLM, NUDT1 | GPR3 3932/4885ALDH1A1 1780/4885CASP3 3903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.